Galera Therapeutics, Inc.
DelistedCIK 1563577fmd_13RVDNEABJ92E8BGM8S4076KQYManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Mar 31, 2026, 33 periods
Latest annual · FY2025
Millions- Operating income
- (3)
- Net income
- 149
- Free cash flow
- (12)
Latest quarter · Q1 FY2026
Millions- Operating income
- (2)
- Net income
- (2)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2020 to FY2025
- n/m
Galera Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$2.5 million | -$20.2 million | 10-K 2026-03-19 · proof | |
| Net income | $149 million | -$19 million | 10-K 2026-03-19 · proof | |
| Cash from operating activities | -$6 million | -$12.1 million | 10-K 2026-03-19 · proof | |
| Total assets | $7.2 million | $10.1 million | -28.8% | 10-K 2026-03-19 · proof |
| Total liabilities | $645,000 | $153.8 million | -99.6% | 10-K 2026-03-19 · proof |
| Cash and cash equivalents | $6.4 million | $8.3 million | -23.1% | 10-K 2026-03-19 · proof |
- What was Galera Therapeutics, Inc.'s operating income in fiscal 2025?
- Galera Therapeutics, Inc. reported operating income of -$2.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$20.2 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2026. SEC
- What was Galera Therapeutics, Inc.'s net income in fiscal 2025?
- Galera Therapeutics, Inc. reported net income of $149 million for fiscal 2025 (the year ended Dec 31, 2025), against -$19 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2026. SEC
- What was Galera Therapeutics, Inc.'s cash from operating activities in fiscal 2025?
- Galera Therapeutics, Inc. reported cash from operating activities of -$6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$12.1 million the year before. Source: the 10-K filed with the SEC on Mar 19, 2026. SEC
- What are Galera Therapeutics, Inc.'s total assets?
- As of Dec 31, 2025, Galera Therapeutics, Inc. reported total assets of $7.2 million, against $10.1 million a year earlier (-28.8%). Source: the 10-K filed with the SEC on Mar 19, 2026. SEC
- What are Galera Therapeutics, Inc.'s total liabilities?
- As of Dec 31, 2025, Galera Therapeutics, Inc. reported total liabilities of $645,000, against $153.8 million a year earlier (-99.6%). Source: the 10-K filed with the SEC on Mar 19, 2026. SEC
- What are Galera Therapeutics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2025, Galera Therapeutics, Inc. reported cash and cash equivalents of $6.4 million, against $8.3 million a year earlier (-23.1%). Source: the 10-K filed with the SEC on Mar 19, 2026. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1563577&period_type=annual&limit=5"Information only, not investment advice.